{"id":"W3031292296","doi":"10.1200/jco.2020.38.15_suppl.3064","title":"Results of a first-in-human phase I study of SRF231, a fully human, high-affinity anti-CD47 antibody.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Dosing; Neutropenia; Pharmacodynamics; Pharmacokinetics; Adverse effect; Internal medicine; Cmax; Antibody; Anemia; Oncology; Leukopenia; Pharmacology; Gastroenterology; Toxicity; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002773928,0.001590064,0.001495562,0.0003382438,0.0004752317,0.001184951,0.0007808923,0.001237275,0.004196337],"category_scores_gemma":[0.001149751,0.000519868,0.001135701,0.0002908638,0.0006195903,0.0006986207,0.0002822592,0.002609649,0.001535611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00100591,"about_ca_system_score_gemma":0.001801605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001706704,"about_ca_topic_score_gemma":0.002838299,"domain_scores_codex":[0.9992704,0.000307848,0.00003469223,0.0001073349,0.000106349,0.0001733538],"domain_scores_gemma":[0.9989506,0.0001671487,0.0001675904,0.0001098787,0.0001325884,0.0004722645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3151405,0.1603339,0.01756147,0.001613627,0.004683934,0.00145242,0.0008211197,0.009434661,0.2317631,0.0006897615,0.04981133,0.2066943],"study_design_scores_gemma":[0.1416026,0.7340975,0.04372561,0.00008902475,0.002066684,0.002290193,0.0001488044,0.002392241,0.0395236,0.0006509678,0.03331597,0.00009680213],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9630114,0.007001804,0.004453456,0.001300634,0.000300197,0.005579592,0.01101302,0.0003839362,0.006955981],"genre_scores_gemma":[0.9631847,0.003164973,0.003934463,0.001907783,0.0001537293,0.002764127,0.01786948,0.0001406046,0.006880124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004196337,"threshold_uncertainty_score":0.01467007,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1373446329578081,"score_gpt":0.4665843386607119,"score_spread":0.3292397057029038,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}